Catheter infection statistics at a glance
Catheter-associated infection data is unusually concentrated: one device, a small set of clinical pathways, and a large share of hospital-acquired urinary infections. That makes the numbers useful both for infection-prevention teams and for anyone trying to understand where the biggest risks sit.
Table of contents
- Fast facts
- Why catheter infection statistics matter
- Core prevalence and burden
- Hospital and nursing home exposure
- Outcomes, length of stay, and cost
- Preventability and surveillance gaps
- Pathogens and resistance patterns
- What the numbers say about risk over time
Fast facts
Big number: urinary tract infections account for more than 30% of infections reported by acute care hospitals (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
National burden: surveillance data estimated more than 560,000 nosocomial UTIs annually in U.S. hospitals (CDC CAUTI Toolkit).
Death burden: attributable deaths from UTI were estimated at 13,000 annually (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
Economic burden: CAUTI increases national costs by about $0.4-0.5 billion per year (CDC CAUTI Toolkit).
Exposure window: risk of bacteriuria approaches 100% after 30 days of catheterization (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
Why catheter infection statistics matter
Catheter infection statistics matter because they describe a preventable chain of events that starts with a common medical device and ends with higher costs, longer stays, and avoidable harm. The dataset shows that this is not a narrow specialty issue; it is a mainstream hospital safety problem with reach into acute care, long-term care, and surveillance policy.
A few figures frame the scale clearly. CAUTI adds an estimated 2-4 excess hospital days per case (CDC CAUTI Toolkit). It also raises annual national costs by roughly $0.4-0.5 billion (CDC CAUTI Toolkit). On the clinical side, hospital-associated bloodstream infection from a urinary source had a 32.8% case fatality in the cited CDC/Chenoweth et al. review. Those three numbers together explain why catheter infection prevention is so closely tied to quality improvement.
At a glance
- Urinary tract infections represent a large share of acute care hospital infections (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- More than 560,000 nosocomial UTIs were estimated annually in U.S. hospitals (CDC CAUTI Toolkit).
- About 15%-25% of hospitalized patients receive urinary catheters during their stay (CDC CAUTI Toolkit).
- About 5%-10% of nursing home residents have urinary catheters (CDC CAUTI Toolkit).
- The daily bacteriuria risk with catheterization is 3%-10% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
Core prevalence and burden
Catheter infection statistics start with the burden of urinary infection itself. The CDC guideline says urinary tract infections account for more than 30% of infections reported by acute care hospitals. In the same source set, the 2002 U.S. healthcare-associated infection mortality survey estimated more than 560,000 infections and identified UTI as the highest total among HAIs (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
That same survey also estimated more than 13,000 attributable UTI deaths, with a 2.3% mortality rate (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). The burden is therefore not only common, but consequential.
The CDC CAUTI Toolkit further estimated:
- More than 560,000 nosocomial UTIs annually in U.S. hospitals.
- 13,000 annual attributable deaths from UTI.
- 2-4 excess hospital days per CAUTI case.
- $0.4-0.5 billion in national annual excess cost.
Those estimates do not describe mild inconvenience. They point to a persistent safety and resource problem that affects throughput, staffing, and patient outcomes across the system.
Hospital and nursing home exposure
The exposure side of catheter infection statistics is just as important as the infection side. The dataset shows that catheter use is common in both hospitals and long-term care.
In hospitals, about 15%-25% of hospitalized patients receive urinary catheters during their stay (CDC CAUTI Toolkit). A similar figure appears in the CDC guideline, which states that between 15% and 25% of hospitalized patients may receive short-term indwelling urinary catheters (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). Another source in the dataset says about 20% of patients have a urinary catheter placed at some time during their hospital stay (Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections).
In long-term care, the toolkit says about 5%-10% of nursing home residents have urinary catheters, translating to 75,000-150,000 nursing home residents with catheters (CDC CAUTI Toolkit). The guideline gives a similar long-term care prevalence figure of about 5%, and translates that to approximately 50,000 residents with catheters at any given time (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
Exposure summary table
| Setting | Statistic | Source label |
|---|---|---|
| Hospital patients | 15%-25% receive urinary catheters during their stay | CDC CAUTI Toolkit |
| Hospital patients | 15%-25% may receive short-term indwelling urinary catheters | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Hospital patients | About 20% have a catheter placed at some time during stay | Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections |
| Nursing home residents | 5%-10% have urinary catheters | CDC CAUTI Toolkit |
| Nursing home residents | About 5% prevalence, about 50,000 residents with catheters | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
These exposure rates matter because even modest prevalence turns into large absolute numbers when the underlying population is large. That is why the dataset emphasizes both ratios and headcounts.
Why it matters
A device that is used in a quarter of hospitalized patients can drive a large share of preventable infection burden even when the per-patient risk seems moderate. The issue becomes even more concentrated in intensive care and long-term care environments.
Outcomes, length of stay, and cost
Catheter infection statistics become more persuasive when they are translated into operational effects. The dataset gives three particularly useful measures: extra days, direct episode cost, and aggregate national cost.
CAUTI adds 2-4 excess hospital days per case (CDC CAUTI Toolkit). Chenoweth et al. estimated that a CAUTI episode cost $600, rising to $2,800 if CAUTI was associated with a bloodstream infection (Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections). The same source estimated $131 million in national annual excess medical costs from CAUTIs.
The broader CDC toolkit estimate is larger, putting the annual national cost increase at $0.4-0.5 billion (CDC CAUTI Toolkit). The difference likely reflects a broader framing of burden, but the takeaway is consistent: CAUTI is expensive at both the case level and the system level.
Cost and outcome comparison
| Measure | Value | Source label |
|---|---|---|
| Excess hospital stay | 2-4 days per CAUTI case | CDC CAUTI Toolkit |
| Cost per CAUTI episode | $600 | Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections |
| Cost if bloodstream infection is involved | $2,800 | Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections |
| Annual excess medical costs | $131 million | Chenoweth et al., Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections |
| Annual national cost increase | $0.4-0.5 billion | CDC CAUTI Toolkit |
The severity signal appears again in bloodstream-related outcomes. The dataset reports that hospital-associated bloodstream infection from a urinary source had a 32.8% case fatality (CDC/Chenoweth et al. review). Another guideline figure says urinary-source hospital-acquired bacteremias have an associated mortality of about 10% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). Even with the difference in framing, both figures show that urinary-source infection is not an endpoint to dismiss.
Fast facts
- Hospital-associated bloodstream infection from a urinary source: 32.8% case fatality (CDC/Chenoweth et al. review).
- Urinary-source hospital-acquired bacteremia mortality: about 10% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- CAUTI can add 2-4 extra hospital days per case (CDC CAUTI Toolkit).
- National annual excess medical costs range from $131 million to $0.4-0.5 billion, depending on the estimate used (Chenoweth et al.; CDC CAUTI Toolkit).
Preventability and surveillance gaps
A useful statistic is one that points toward action, and the dataset gives several that do exactly that. The guideline estimates that 17%-69% of CAUTIs may be preventable with recommended infection-control measures (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). It further translates that into up to 380,000 infections prevented annually and about 9,000 deaths prevented annually (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
That range is wide, which is itself important. It suggests that prevention is not a single intervention problem; it is a bundle of decisions around insertion, maintenance, review, and timely removal.
The surveillance section of the toolkit points to a second problem: monitoring gaps. It says more than 50% of surveyed U.S. hospitals did not monitor which patients were catheterized, and about 75% did not monitor catheter duration or discontinuation (CDC CAUTI Toolkit). Those are not small process misses. They are structural barriers to knowing where catheters are, how long they stay in place, and when they should come out.
HHS also set a national 5-year prevention target of a 25% decrease from baseline in symptomatic UTI per 1,000 catheter days (CDC CAUTI Toolkit). That target is useful because it ties prevention to a rate measure, not just a raw count.
Prevention takeaways
- Prevention potential is substantial: 17%-69% of CAUTIs may be preventable (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- The prevention upside is large in absolute terms: up to 380,000 infections and 9,000 deaths prevented annually (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- Measurement gaps are common: many hospitals do not track catheter presence or duration consistently (CDC CAUTI Toolkit).
- A rate-based target exists: 25% reduction in symptomatic UTI per 1,000 catheter days over 5 years (CDC CAUTI Toolkit).
Pathogens and resistance patterns
The dataset also shows that catheter infection statistics are not about one organism. The pathogen mix is broad, and it includes both bacteria and yeast.
In NHSN hospitals from 2006-2007, the leading pathogens were:
- Escherichia coli: 21.4% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Candida spp: 21.0% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Enterococcus spp: 14.9% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Pseudomonas aeruginosa: 10.0% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Klebsiella pneumoniae: 7.7% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Enterobacter spp: 4.1% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
That mix matters because the management burden is not only about recognizing infection, but about dealing with a heterogeneous organism profile.
Pathogen table
| Pathogen | Share of CAUTI pathogens | Source label |
|---|---|---|
| Escherichia coli | 21.4% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Candida spp | 21.0% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Enterococcus spp | 14.9% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Pseudomonas aeruginosa | 10.0% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Klebsiella pneumoniae | 7.7% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
| Enterobacter spp | 4.1% | CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections |
Resistance figures sharpen the picture further. About one quarter of E. coli isolates from CAUTI cases were fluoroquinolone-resistant, and about one third of P. aeruginosa isolates were fluoroquinolone-resistant (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). The same source reports multidrug-resistant rates of 4% for P. aeruginosa, 9% for K. pneumoniae, and 21% for Acinetobacter baumannii among isolates from CAUTI cases (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
These resistance percentages suggest that catheter infection management has to account for more than a routine empiric pathway. The organism profile can shift the downstream burden fast.
Resistance snapshot
- E. coli fluoroquinolone resistance: about one quarter (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- P. aeruginosa fluoroquinolone resistance: about one third (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Multidrug-resistant P. aeruginosa: 4% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Multidrug-resistant K. pneumoniae: 9% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
- Multidrug-resistant Acinetobacter baumannii: 21% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections)
What the numbers say about risk over time
Time is one of the clearest themes in catheter infection statistics. The longer the catheter stays in place, the more risk accumulates.
The guideline says the daily risk of bacteriuria with catheterization is 3%-10% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). It also says the risk of bacteriuria approaches 100% after 30 days of catheterization (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). That is the most important time-based finding in the dataset because it shows how quickly the device can shift from useful support to infection risk.
The utilization data back that up. In acute care hospitals reporting to NHSN in 2006, pooled mean urinary catheter utilization ratios in ICU and non-ICU areas ranged from 0.23 to 0.91 catheter-days per patient-day (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). In other words, some settings use catheters far more intensively than others, which helps explain why surveillance and duration tracking matter so much.
Timeline-style reading of the evidence
- Day 1 onward: bacteriuria risk begins accumulating at 3%-10% per day (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- By 30 days: bacteriuria risk approaches 100% (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- At the policy level: HHS set a 25% reduction target over 5 years for symptomatic UTI per 1,000 catheter days (CDC CAUTI Toolkit).
- At the system level: large shares of hospitals were still not monitoring catheter presence or duration in the toolkit survey (CDC CAUTI Toolkit).
The 2009 CDC/NHSN definition change also matters. The revised UTI criteria shortened follow-up after catheter removal from 7 days to 48 hours, and the revised criteria took effect in January 2009 (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections). That change affects how cases are counted and compared across time, which is essential context for anyone interpreting trend lines.
Historical comparison points
- 2006 NHSN catheter utilization ratios ranged from 0.23 to 0.91 catheter-days per patient-day (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- 2006-2007 NHSN pathogen distributions show a mixed organism profile led by E. coli and Candida spp (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- January 2009 marks the revised surveillance definition timing (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
- The follow-up window after catheter removal changed from 7 days to 48 hours (CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections).
Taken together, the data show a clear pattern: catheter infection risk is common, time-sensitive, expensive, and partially preventable. The strongest signals in the dataset are the scale of the exposed population, the steep daily risk accumulation, and the sizable share of infections that prevention programs may be able to avoid.